OCTOBER 2023LIFE SCIENCES REVIEW4Stefano Ferrara, Director, Clinical Science, BeiGeneA proposal for a new strategy in oncology clinical development30LAST WORDIN MY OPINIONSamir Ounzain, Co-founder, Chief Executive Officer & Board Director, Regulatory RNAs, HAYA TherapeuticsThe Dark Side of the Genome Transforming RNA Therapies0812COVER STORYCONTENTSGROUND-BREAKING DISCOVERIES POWERED BY NEXT-GENERATION SEQUENCINGQIAGEN[NYSE: QGEN]QIAGEN [NYSE: QGEN]Peter Hesse, Vice President,Head of Genomic Business
< Page 3 | Page 5 >